At StemX Bio, we’re transforming drug discovery with our ready-to-use human pancreas microtissue model. Our innovative approach, backed by a patent-pending differentiation protocol, empowers researchers to rapidly advance from screening to clinical trials. Our human microtissue models offer unmatched predictive value, robustness, and scalability, accelerating the development of effective and safer therapies for diabetes. Join us in shaping the future of medical research and treatment.
| Website | https://stemxbio.com/ |
| Employees | 5 (2 on RocketReach) |
| Founded | 2024 |
| Phone | +31 6 21307999 |
| Industry | Biotechnology Research |
| Keywords | 3d Cell Culture, In Vitro Models, Diabetes Research, Drug Discovery, Disease Modeling, Drug Screening, Biotechnology, Pharmaceutical Research, Cell-Based Assays, Regenerative Medicine, Preclinical Research, Stem Cell Technology, Tissue Engineering, Cell Therapy, Bioprinting |
Looking for a particular StemX Bio employee's phone or email?
StemX Bio Questions
Jane Spirkoski is the CEO and Co-Founder of StemX Bio.
2 people are employed at StemX Bio.
Top StemX Bio Employees
-
Jane Spirkoski
CEO and Co-Founder at StemX Bio
Leiden, ZH, NL1 -
Elena Naumovska
Chief Scientific Officer at StemX Bio
Leiden, ZH, NL11
G2Crowd Trusted
300K+
Plugin Users
